Get Pharma & Biotech every Monday

One free email with what the biggest companies in Pharma & Biotech filed, were granted and gave up this week.

The Thicket.
Pharma & Biotech / Week of Nov 16, 2026Get it every Monday →
All Pharma & BiotechIssue 001 / Eli Lilly and CompanyThe filing
Eli Lilly and CompanyPublication

Sigilon Therapeutics publishes engineered cells with reduced MHC expression for disease treatment.

The filing

Sigilon Therapeutics published a US application on November 12, 2026, describing engineered mammalian cells designed to treat disease. The application details cells engineered with a reduction in the level or function of major histocompatibility complex (MHC) class I protein complex components, and optionally MHC class II components or CIITA.

This filing’s full text wasn’t read for this issue, so its claims and the applicant’s background aren’t shown. Both are in the record, under Sources.

Expert view

Sigilon Therapeutics published a US application on November 12, 2026, describing engineered mammalian cells designed to treat disease. The application details cells engineered with a reduction in the level or function of major histocompatibility complex (MHC) class I protein complex components, and optionally MHC class II components or CIITA.

Get Pharma & Biotech every Monday.

© 2026 Fearn AI, Inc. All rights reserved.

Information from the public patent record, not legal advice.

Big Law patents. In plain sight.

The all-in-one patent firm for startups. Former Big Law patent experts and PhDs, on AI that runs on our own GPUs.

Social

Newsletter

Stay updated on the future of intellectual property.

Fearn Legal, LLC is a patent prosecution firm, licensed to file and prosecute patents across the USPTO. The information provided here is for general informational purposes only and does not constitute legal advice. Viewing this information or contacting us through this website does not create an attorney-client or patent agent-client relationship. For personalized legal advice, please reach out to us directly to set up a legal consult or consult directly with a qualified attorney.

Big Law patents. In plain sight.

Social

Newsletter

Stay updated on the future of intellectual property.

Fearn Legal, LLC is a patent prosecution firm, licensed to file and prosecute patents across the USPTO. The information provided here is for general informational purposes only and does not constitute legal advice. Viewing this information or contacting us through this website does not create an attorney-client or patent agent-client relationship. For personalized legal advice, please reach out to us directly to set up a legal consult or consult directly with a qualified attorney.

Big Law patents. In plain sight.

The all-in-one patent firm for startups. Former Big Law patent experts and PhDs, on AI that runs on our own GPUs.

Social

Newsletter

Stay updated on the future of intellectual property.

Fearn Legal, LLC is a patent prosecution firm, licensed to file and prosecute patents across the USPTO. The information provided here is for general informational purposes only and does not constitute legal advice. Viewing this information or contacting us through this website does not create an attorney-client or patent agent-client relationship. For personalized legal advice, please reach out to us directly to set up a legal consult or consult directly with a qualified attorney.